ART Under Pressure: Comparing Regimens in Challenging Scenarios

In this interactive case-based activity recorded at a recent live symposium, Anton L. Pozniak, MD, FRCP; José R. Arribas, MD; Daniel R. Kuritzkes, MD; and Fiona Mulcahy, MD, FRCPI, present a series of complex patient cases requiring selection and initiation of antiretroviral therapy.
Anton L. Pozniak, MD, FRCP
Program Director
José R. Arribas, MD
Daniel R. Kuritzkes, MD
Fiona Mulcahy, MD, FRCPI
Physicians: maximum of 1.25 AMA PRA Category 1 Credits
Registered Nurses: 1.1 Nursing contact hours
Released: January 6, 2017 Expiration: January 5, 2018

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Select optimal first-line ART regimens for diverse patient types
  • Identify virologically suppressed patients who are appropriate candidates for switching to newer ART regimens
  • Provide individualized care for more challenging patients to optimize treatment outcomes

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Program Director

Anton L. Pozniak, MD, FRCP

Consultant Physician
Director of HIV Services

Department of HIV and Genitourinary Medicine
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom

Anton L. Pozniak, MD, FRCP, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV; fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from Gilead Sciences; and funds for research support from Gilead Sciences, Janssen, Merck, and ViiV.

Faculty

José R. Arribas, MD

Research Director (HIV and Infectious Diseases)
Hospital La Paz. IdiPAZ.
Madrid, Spain

José R. Arribas, MD, has disclosed that he has received consulting fees from Gilead Sciences and Merck and fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Sharp and Dohme, and ViiV.

Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, Merck, and ViiV; fees for non-CME/CE services from Gilead Sciences; and funds for research support from Gilead Sciences.

Fiona Mulcahy, MD, FRCPI

Consultant Genitourinary Physician
St James Hospital
Professor
Department of Medicine
Trinity College
Dublin, Ireland

Fiona Mulcahy, MD, FRCPI, has disclosed that she has received consulting fees from Gilead Sciences.

Staff

Edward King, MA

Executive Vice President

Edward King, MA, has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Clinical Editor

Megan K. Murphy, PhD, has real or apparent conflicts of interest to report.

Anna Poppa

Editorial Contributor

Anna Poppa has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, MBA, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.


The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for physicians, registered nurses, and other healthcare providers caring for patients with HIV infection.

Goal

The goal of this activity is to improve participants’ competence in selecting antiretroviral therapy regimens in settings where therapy choices must be individualized to optimize outcomes.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.1 contact hours may be earned for successful completion of this activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 06, 2017, through January 05, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.

Related Content

Watch an HIV expert panel discuss managing HCV infection in MSM, prescribing HIV PrEP to a PWID, and managing CVD in an HIV-infected woman.

W. David Hardy, MD
Program Director
Princy N. Kumar, MD person default Jaimie P. Meyer, MD, MS, FACP Babafemi Taiwo, MBBS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 18, 2018 Expiration: June 17, 2019

CME-certified expert panel discussion on initiating or switching ART in a series of challenging patient cases.

Monica Gandhi, MD, MPH
Program Director
Eric S. Daar, MD Sally Hodder, MD Babafemi Taiwo, MBBS
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.13 CEUs) Released: June 15, 2018 Expiration: June 14, 2019

In this downloadable slideset, Frederick L. Altice, MD, reviews the HIV treater’s role at the intersection of HIV infection, HCV infection, and the opioid crisis.

Released: April 26, 2018

Listen to downloadable audio from a series of live Webinars by Paul E. Sax, MD, and Brian Wood, MD, in which the use of recently approved integrase inhibitor–based regimens is discussed and audience questions on this subject are addressed.

Released: April 23, 2018

Acknowledgements

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by an independent educational grant from
ViiV Healthcare

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?